Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Baxter
Healthtrust
Cipla
Argus Health
UBS
US Army
Citi
Dow

Generated: June 25, 2018

DrugPatentWatch Database Preview

PROPOXYPHENE HYDROCHLORIDE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Propoxyphene Hydrochloride patents expire, and when can generic versions of Propoxyphene Hydrochloride launch?

Propoxyphene Hydrochloride is a drug marketed by Alra, Impax Labs, Ivax Sub Teva Pharms, Mutual Pharm, Mylan, Nexgen Pharma Inc, Par Pharm, Purepac Pharm, Pvt Form, Roxane, Sandoz, Teva, Valeant Pharm Intl, Vintage Pharms, Watson Labs, West Ward, Whiteworth Town Plsn, and Warner Chilcott. and is included in thirty-two NDAs.

The generic ingredient in PROPOXYPHENE HYDROCHLORIDE is aspirin; caffeine; propoxyphene hydrochloride. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; caffeine; propoxyphene hydrochloride profile page.
Summary for PROPOXYPHENE HYDROCHLORIDE
Drug patent expirations by year for PROPOXYPHENE HYDROCHLORIDE
Synonyms for PROPOXYPHENE HYDROCHLORIDE
(+)-1,2-Diphenyl-2-propionoxy-3-methyl-4-dimethylaminobutane hydrochloride
(+)-Propoxyphene hydrochloride
(|AS)-|A-[(1R)-2-(Dimethylamino)-1-methylethyl]-|A-phenylbenzeneethanol Propanoate Hydrochloride
(2S,3R)-(+)-4-(Dimethylamino)-3-methyl-1,2-diphenyl-2-butanol propionate (ester) hydrochloride
(2S,3R)-(+)-4-(Dimethylamino)-3-methyl-1,2-diphenyl-2-butanol propionate hydrochloride
[(1S,2R)-1-benzyl-3-(dimethylamino)-2-methyl-1-phenyl-propyl] propanoate hydrochloride
[(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate hydrochloride
[(2S,3R)-4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate;hydrochloride
[4-(dimethylamino)-3-methyl-1,2-diphenylbutan-2-yl] propanoate hydrochloride
1639-60-7
2-Butanol, 4-(dimethylamino)-3-methyl-1,2-diphenyl-, propionate (ester), hydrochloride, (+)-
2-Butanol, 4-(dimethylamino)-3-methyl-1,2-diphenyl-, propionate (ester), hydrochloride, (L)-
25312-78-1
56533-07-4
62-69-1
6414-50-2
642 Tablets
6585-54-2
Abalgin
AC1L25NW
AC1L25VI
Algaphan
alpha-d-Propoxyphene hydrochloride
AN-20665
Anatalvic
API0002285
Benzeneethanol, ?-[2-(dimethylamino) -1-methylethyl]-?-phenyl-, propanoate (ester), hydrochloride, [S-(R,S)]-
Benzeneethanol, .alpha.-[(1R)-2-(dimethylamino)-1-methylethyl]-.alpha.-phenyl-, 1-propanoate, hydrochloride (1:1), (.alpha.S)-
Benzeneethanol, alpha-((1R)-2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, 1-propanoate, hydrochloride (1:1), (alphaS)-
Benzeneethanol, alpha-((1R)-2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, propanoate (ester), hydrochloride, (alphaS)-
Benzeneethanol, alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, propanoate (ester), hydrochloride, (S-(R*,S*))-
Benzeneethanol, alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenyl-, propanoate (ester), hydrochloride, (S-(theta,S))-
CAS-1639-60-7
CB2TL9PS0T
CHEBI:8498
CHEMBL1237104
d-4-Dimethylamino-3-methyl-1,2-diphenyl-2-butanol propionate hydrochloride
D-propoxyphene hydrochloride methanol*solution
d-Propoxyphene monohydrochloride
D00482
D03HCZ
Darvon
Darvon (TN)
Darvon with A.S.A
Darvon with A.S.A.
DEA No. 9278
Deprancol
Depronal
Depronal retard
Develin
Dextro Propoxyphene HCl
Dextropropofixen Dak
DEXTROPROPOXIPHENE CHLORIDE
Dextropropoxyphene hydrochloride
Dolene
Dolotard
Doloxene
Doraphen
DSSTox_CID_28839
DSSTox_GSID_48913
DSSTox_RID_83108
DTXSID6048913
EINECS 216-484-3
EINECS 216-683-5
Erantin
FT-0674086
Kesso-Gesic
L-Propoxyphene hydrochloride
Levopropoxyphene hydrochloride
Liberen
LS-46519
LS-46520
Mardon
Margesic Improved
NCGC00247706-01
Novopropoxyn
OR070907
OR210775
Paljin
Prophene
Prophene 65
Propoxyphene HCl
Propoxyphene hydrochloride (USP)
Propoxyphene hydrochloride [USAN:USP]
Propoxyphene hydrochloride [USAN]
Propoxyphene hydrochloride 65
Propoxyphene Hydrochloride Salt
Propoxyphene-d7 Hydrochloride Salt (Mixture of Diastereoisomers)
Propoxyphene-d7 hydrochloride salt(mixture of diastereoisomers)
QMQBBUPJKANITL-MYXGOWFTSA-N
Romidon
s-alpha-(2-(Dimethylamino)-1-methylethyl)-alpha-phenylbenzeneethanol propioate hydrochloride
SCHEMBL41779
SCHEMBL9269
SK-65 Apap
Tox21_112860
UNII-CB2TL9PS0T
W-109688
Zideron

US Patents and Regulatory Information for PROPOXYPHENE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN acetaminophen; propoxyphene hydrochloride TABLET;ORAL 040139-001 Dec 16, 1996 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN acetaminophen; propoxyphene hydrochloride TABLET;ORAL 083689-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs PROPOXYPHENE HYDROCHLORIDE W/ ASPIRIN AND CAFFEINE aspirin; caffeine; propoxyphene hydrochloride CAPSULE;ORAL 085732-002 Sep 3, 1984 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Mylan PROPOXYPHENE HYDROCHLORIDE AND ACETAMINOPHEN acetaminophen; propoxyphene hydrochloride TABLET;ORAL 083978-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Argus Health
Harvard Business School
Chinese Patent Office
US Department of Justice
Deloitte
Cantor Fitzgerald
Cerilliant
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.